Searchable abstracts of presentations at key conferences in endocrinology

ea0073aep143 | Calcium and Bone | ECE2021

Postsurgical hungry bone syndrome in unrecognized severe primary hyperparathyroidism: A case report

Ilijevska Cvetanka Volkanovska , Zivkovic Marija , Stevchevska Aleksandra , Otovikj Natasha Eftimovska , Hasan Taner , Mishevska Sasha Jovanovska

Parathyroidectomy for hyperparathyroidism can be complicated with development of Hungry Bone Syndrome (HBS), a constellation of profound hypocalcemia with hypomagnesemia and hypophosphatemia. The severity of this potential life-threatening condition is related to the extent of the parathyroid-mediated high-turnover bone disease. We present a case of a 59-year-old woman developing post-surgical HBS as a result of longstanding severe unrecognized primary hyperparathyroidism (PHP...

ea0075a04 | Adrenal gland | EYES2021

Cyclic ectopic Cushing’ssyndromedue to bronchial carcinoid tumor: diagnostic challenge

Medenica Sanja , Stojanovic Milos , Nedeljkovic Beleslin Biljana , Stojkovic Mirjana , Miletic Marija , Zarkovic Milos , Ciric Jasmina

Background: Ectopic Cushing’s syndrome (ECS) frequently represents a diagnostic challenge due to its complex clinical presentation.Case presentation: A 57-year-old male presented with typical Cushingoid appearance, high adrenocorticotropic hormone (ACTH) level (138.3 pg/ml), lack of cortisol circadian rhythm and suppression in overnight 1 mg dexamethasone suppression test (DST) (1374 nmol/l). Great daily fluctuation of serum cortisol levels from ver...

ea0092ps3-30-09 | Thyroid Physiology in Periphery & Development Basic | ETA2023

Desiccated thyroid powder: old-new therapy of hypothyroidism and quantitative analysis of triiodothyronine and thyroxine in the pharmceutical preparation

Jovanović Mihaela , Frkanec Ruža , Frkanec Leo , Tavčar Branka , Letfus Marija

Personalized medicine is a crucial part of modern medicine. As a result, other therapeutic options apart from levothyroxine are considered when treating hypothyroidism. Desiccated thyroid pharmaceuticals, that in addition to thyroxine (T4), contain triiodothyronine (T3), are one of them. ETA recognized the rapid use of desiccated thyroid pharmaceuticals and described specific guidelines for its utilization. The biggest problem of their use is unresolved issues of content that ...

ea0093p5 | Guided Poster Tour 1: Adrenal and Neuroendocrine tumors | EYES2023

An overview of adrenal vein sampling for primary aldosteronism in Croatia (2016–2023)

Lekić Ivan , Tomšić Karin Zibar , Alduk Ana Marija , Kaštelan Darko

Background: Although adrenal vein sampling (AVS) is a technically demanding procedure, it is still considered the gold standard for subtyping primary aldosteronism (PA). The aim of the study was to analyze the success rate of AVS in patients with PA.Methods: In all patients AVS was performed sequentially during continuous stimulation with adrenocorticotrophic hormone by one interventional radiologist. Adrenal vein cannulation was considered successful if...

ea0041oc14.2 | Thyroid Cancer | ECE2016

Complex immunometabolic pathways mediate the interaction between thyroid carcinoma cells and tumor-associated macrophages

Arts Rob , Plantinga Theo , Heinhuis Bas , Tuit Sander , Petrulea Mirela , Tesselaar Marika , Sloot Yvette , Kusters Benno , Joosten Leo , Georgescu Carmen , Smit Johannes , Netea Mihai , Schulze Joakim , Netea-Maier Romana

Background: Tumor-associated macrophages (TAMs) with dysregulated inflammatory phenotypes play a key role in carcinogenesis. In thyroid carcinoma (TC), excessive release of proinflammatory cytokines decreases the expression of sodium-iodine transporter and inflammation potentiates tumor progression.Aim: To assess the impact of TC cells on the functional reprograming of TC-induced macrophages at the level of transcriptome and metabolic pathways, and asses...

ea0056gp201 | Pituitary Basic | ECE2018

Epigenetic and post-transcriptional regulation of the SSTR5 gene in somatotropinomas

Pedraza-Arevalo Sergio , Ibanez-Costa Alejandro , Vazquez-Borrego M Carmen , Branco Miguel , Galvez-Moreno M Angeles , Soto-Moreo Alfonso , Korbonits Marta , Gahete Manuel D , Charalambous Marika , Luque Raul M , Castano Justo P

The somatostatin receptor 5 (sst5) and its truncated splicing variants (sst5TMD5, sst5TMD4) are considered putative biomarkers that can predict pharmacological response or aggressiveness in several endocrine-related pathologies, such as acromegaly. sst5 is encoded by a gene, SSTR5, that lacks introns within its coding sequence, and hence, the splicing variants identified are generated by non-canonical splicing events. However, the mechanisms underlying their genesis a...

ea0081p36 | Calcium and Bone | ECE2022

Denosumab vs. zoledronic acid treatment in post-menopausal breast cancer: a 2-year prospective observational study

Buch-Larsen Kristian , Marina Djordje , Schwarz Peter

Adjuvant treatment for post-menopausal women with early breast cancer (BC) includes aromatase inhibitors (AI), known to decrease bone mineral density (BMD). In this study, we investigate whether denosumab is a valid second option for patients unable to receive standard adjuvant i.v. zoledronic acid (ZA). In total, 212 patients have been evaluated after they did not receive ZA. Of those 194 were included. After evaluation by an endocrinologist, all patients were offered ZA as t...

ea0081ep78 | Adrenal and Cardiovascular Endocrinology | ECE2022

Subthreshold cortisol deficiency-another ray in the spectrum?

Adamidou Foteini , Komzia Paraskevi , Kita Marina

Introduction: In Endocrinology, subclinical disorders meet certain diagnostic laboratory thresholds, but are by definition asymptomatic. Subthreshold disorders in Endocrinology have not been defined. We describe two cases of cortisol deficiency, primary and secondary, with normal baseline cortisol, which were by presentation clinical, but could be characterized as subthreshold by biochemical cut-off criteria.Case 1: A 47-year-old woman was referred for a...

ea0081ep1177 | Late Breaking | ECE2022

Prolonged oral glucose tolerance test in the diagnosis of postprandial non-diabetic hypoglycemia

Yukina Marina , Nuralieva Nurana , Troshina Ekaterina

Introduction: tests alternative to the fasting test are necessary for the diagnosis of numerous causes of non-diabetic hypoglycaemia (NDH), that not provoked by starvation (postprandial hypoglycemia), such as insulin autoimmune syndrome (IAS) and noninsulinoma pancreatogenous hypoglycemia syndrome (NIPHS). However, there is no consensus on the most optimal test (prolonged oral glucose tolerance test (pOGTT) or mixed meal test (MMT)) in this cohort of patients.<p class="abs...

ea0090ep1116 | Late Breaking | ECE2023

Nondiabetic hypoglycemia: the role of psycho-neurological care in primary diagnosis

Yukina Marina , Nuralieva Nurana , Troshina Ekaterina

Introduction: Decreased glycemia in patients without diabetes mellitus (nondiabetic hypoglycemias; NDH) is a manifestation of severe diseases from endocrinopathies to malignant tumors. The most specific symptom of NDH is association of attack with the intake of carbohydrate-containing food. Hypoglycemia is usually manifested by neurological and mental disorders, and therefore, patients initially seek medical help not from an endocrinologist, but from psychiatrists and neurolog...